Clinical study of analgesic effect and immune stress of posterior laminar block guided by ultrasound in patients undergoing percutaneous nephrolithotripsy

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100046975

Enrollment

Unknown

Registered

2021-06-06

Start date

2021-06-06

Completion date

Unknown

Last updated

2022-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Analgesic effect

Interventions

group 1:General anesthesia combined with posterior laminar block

group2:General anesthesia

Eligibility

Sex/Gender

All

Age

20 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Patients with elective percutaneous nephrolithotomy, aged 20to 60 years, weighing 45-75kg; 2. ASA grades are all I-II grades, regardless of gender.

Exclusion criteria

Exclusion criteria: 1. Long-term use of analgesics; 2. Past history of kidney surgery; 3. Severe coagulation dysfunction and blood system diseases; 4. Local anesthetic allergy; systemic or puncture site infection; cognitive and language barriers that hinder participation; 5. Other conditions that the researcher believes that the patient does not meet the conditions of this study.

Design outcomes

Primary

Measure	Time frame
Intraoperative dosage of remifentanil;Number of postoperative acute analgesia;	—

Secondary

Measure	Time frame
Postoperative pain score;Extubation time;The first time to get out of bed after surgery;Hemodynamic index;immune indice;stress index;	—

Countries

China

Contacts

Public ContactXiao Yun

Jinzhou Medical University, Hubei College of Medicine, Postgraduate training base

xiaoyun5598@163.com+86 15907287568

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026